Choi, Hannuy
Ryu, Ik Hee
Lee, In Sik
Kim, Jin Kuk
Yoo, Tae Keun http://orcid.org/0000-0003-0890-8614
Article History
Received: 12 April 2024
Accepted: 23 July 2024
First Online: 30 July 2024
Declarations
:
: This study was approved by the Institutional Review Board of the Korean National Institute for Bioethics Policy (KNIBP; no. 2023–0860-001), which waived the requirement for informed consent. All research methods were performed in accordance with the Declaration of Helsinki and KNIBP guidelines. The Institutional Review Board waived the requirement for informed consent because the data were fully de-identified, thereby protecting patient confidentiality.
: Not applicable.
: Ik Hee Ryu and Jin Kuk Kim are directors at VISUWORKS and own company stock. Ik Hee Ryu serves on the Advisory Board for Carl Zeiss Meditec AG and Avellino Lab USA/MAB for Avellino Lab Korea. Jin Kuk Kim is an executive of the Korea Intelligent Medical Industry Association (KIMIA). Tae Keun Yoo is an employee of VISUWORKS and receives salary and stock as part of the standard compensation package. The remaining authors declare no conflicts of interest.